|
RNF34 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.811580E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.625800E-01 |
| Normal-vs-Stage2 |
4.275800E-01 |
| Normal-vs-Stage3 |
6.637500E-02 |
| Normal-vs-Stage4 |
9.425800E-02 |
| Stage1-vs-Stage2 |
7.396200E-01 |
| Stage1-vs-Stage3 |
1.525400E-01 |
| Stage1-vs-Stage4 |
2.591200E-01 |
| Stage2-vs-Stage3 |
5.054600E-01 |
| Stage2-vs-Stage4 |
5.224600E-01 |
| Stage3-vs-Stage4 |
9.779200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.168600E-01 |
| Normal-vs-AfricanAmerican |
2.439600E-01 |
| Normal-vs-Asian |
9.775400E-01 |
| Caucasian-vs-AfricanAmerican |
6.362600E-01 |
| Caucasian-vs-Asian |
4.470600E-01 |
| AfricanAmerican-vs-Asian |
3.500200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.282360E-01 |
| Normal-vs-Female |
2.580800E-01 |
| Male-vs-Female |
5.224000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.053600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.159200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.850200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.931800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.739600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.437700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.095970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.745010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.058400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.900200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.688310E-02 |
| Classical-VS-Follicular |
2.900900E-03 |
| Classical-VS-Other |
1.712010E-01 |
| Classical-VS-Normal |
9.526200E-01 |
| Tall-VS-Follicular |
9.477600E-01 |
| Tall-VS-Other |
8.881800E-01 |
| Tall-VS-Normal |
2.540100E-02 |
| Follicular-VS-Other |
9.321400E-01 |
| Follicular-VS-Normal |
1.437940E-02 |
| Other-VS-Normal |
3.617000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.171420E-01 |
| Normal-vs-N1 |
2.065600E-02 |
| N0-vs-N1 |
2.272600E-01 |
|
|
